179 related articles for article (PubMed ID: 17149867)
1. 2-triazole-substituted adenosines: a new class of selective A3 adenosine receptor agonists, partial agonists, and antagonists.
Cosyn L; Palaniappan KK; Kim SK; Duong HT; Gao ZG; Jacobson KA; Van Calenbergh S
J Med Chem; 2006 Dec; 49(25):7373-83. PubMed ID: 17149867
[TBL] [Abstract][Full Text] [Related]
2. (N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists.
Tchilibon S; Joshi BV; Kim SK; Duong HT; Gao ZG; Jacobson KA
J Med Chem; 2005 Mar; 48(6):1745-58. PubMed ID: 15771421
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of truncated C2- or C8-substituted adenosine derivatives as dual acting A₂A and A₃ adenosine receptor ligands.
Hou X; Majik MS; Kim K; Pyee Y; Lee Y; Alexander V; Chung HJ; Lee HW; Chandra G; Lee JH; Park SG; Choi WJ; Kim HO; Phan K; Gao ZG; Jacobson KA; Choi S; Lee SK; Jeong LS
J Med Chem; 2012 Jan; 55(1):342-56. PubMed ID: 22142423
[TBL] [Abstract][Full Text] [Related]
4. "Reversine" and its 2-substituted adenine derivatives as potent and selective A3 adenosine receptor antagonists.
Perreira M; Jiang JK; Klutz AM; Gao ZG; Shainberg A; Lu C; Thomas CJ; Jacobson KA
J Med Chem; 2005 Jul; 48(15):4910-8. PubMed ID: 16033270
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of truncated adenosine derivatives as highly potent and selective human A3 adenosine receptor antagonists.
Pal S; Choi WJ; Choe SA; Heller CL; Gao ZG; Chinn M; Jacobson KA; Hou X; Lee SK; Kim HO; Jeong LS
Bioorg Med Chem; 2009 May; 17(10):3733-8. PubMed ID: 19375920
[TBL] [Abstract][Full Text] [Related]
6. Structure-guided design of A(3) adenosine receptor-selective nucleosides: combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutions.
Tosh DK; Deflorian F; Phan K; Gao ZG; Wan TC; Gizewski E; Auchampach JA; Jacobson KA
J Med Chem; 2012 May; 55(10):4847-60. PubMed ID: 22559880
[TBL] [Abstract][Full Text] [Related]
7. N6-Substituted adenosine derivatives: selectivity, efficacy, and species differences at A3 adenosine receptors.
Gao ZG; Blaustein JB; Gross AS; Melman N; Jacobson KA
Biochem Pharmacol; 2003 May; 65(10):1675-84. PubMed ID: 12754103
[TBL] [Abstract][Full Text] [Related]
8. Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary.
Gao ZG; Kim SK; Biadatti T; Chen W; Lee K; Barak D; Kim SG; Johnson CR; Jacobson KA
J Med Chem; 2002 Sep; 45(20):4471-84. PubMed ID: 12238926
[TBL] [Abstract][Full Text] [Related]
9. N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
Volpini R; Dal Ben D; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G
J Med Chem; 2007 Mar; 50(6):1222-30. PubMed ID: 17309246
[TBL] [Abstract][Full Text] [Related]
10. 5'-C-Ethyl-tetrazolyl-N(6)-substituted adenosine and 2-chloro-adenosine derivatives as highly potent dual acting A1 adenosine receptor agonists and A3 adenosine receptor antagonists.
Petrelli R; Torquati I; Kachler S; Luongo L; Maione S; Franchetti P; Grifantini M; Novellino E; Lavecchia A; Klotz KN; Cappellacci L
J Med Chem; 2015 Mar; 58(5):2560-6. PubMed ID: 25699637
[TBL] [Abstract][Full Text] [Related]
11. Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors.
Alnouri MW; Jepards S; Casari A; Schiedel AC; Hinz S; Müller CE
Purinergic Signal; 2015 Sep; 11(3):389-407. PubMed ID: 26126429
[TBL] [Abstract][Full Text] [Related]
12. Flexible modulation of agonist efficacy at the human A3 adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000.
Gao ZG; Ye K; Göblyös A; Ijzerman AP; Jacobson KA
BMC Pharmacol; 2008 Dec; 8():20. PubMed ID: 19077268
[TBL] [Abstract][Full Text] [Related]
13. Structural determinants of efficacy at A3 adenosine receptors: modification of the ribose moiety.
Gao ZG; Jeong LS; Moon HR; Kim HO; Choi WJ; Shin DH; Elhalem E; Comin MJ; Melman N; Mamedova L; Gross AS; Rodriguez JB; Jacobson KA
Biochem Pharmacol; 2004 Mar; 67(5):893-901. PubMed ID: 15104242
[TBL] [Abstract][Full Text] [Related]
14. 2,8-Disubstituted adenosine derivatives as partial agonists for the adenosine A2A receptor.
van Tilburg EW; Gremmen M; von Frijtag Drabbe Künzel J; de Groote M; IJzerman AP
Bioorg Med Chem; 2003 May; 11(10):2183-92. PubMed ID: 12713828
[TBL] [Abstract][Full Text] [Related]
15. 5-amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a versatile scaffold to obtain potent and selective A3 adenosine receptor antagonists.
Da Settimo F; Primofiore G; Taliani S; Marini AM; La Motta C; Simorini F; Salerno S; Sergianni V; Tuccinardi T; Martinelli A; Cosimelli B; Greco G; Novellino E; Ciampi O; Trincavelli ML; Martini C
J Med Chem; 2007 Nov; 50(23):5676-84. PubMed ID: 17927167
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of 2-chloro-N6-substituted-4'-thioadenosine-5'-uronamides as highly potent and selective agonists at the human A3 adenosine receptor.
Jeong LS; Lee HW; Jacobson KA; Kim HO; Shin DH; Lee JA; Gao ZG; Lu C; Duong HT; Gunaga P; Lee SK; Jin DZ; Chun MW; Moon HR
J Med Chem; 2006 Jan; 49(1):273-81. PubMed ID: 16392812
[TBL] [Abstract][Full Text] [Related]
17. 2-Substituted adenosine derivatives: affinity and efficacy at four subtypes of human adenosine receptors.
Gao ZG; Mamedova LK; Chen P; Jacobson KA
Biochem Pharmacol; 2004 Nov; 68(10):1985-93. PubMed ID: 15476669
[TBL] [Abstract][Full Text] [Related]
18. N6,5'-Disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor.
van Tilburg EW; von Frijtag Drabbe Künzel J; de Groote M; Vollinga RC; Lorenzen A; IJzerman AP
J Med Chem; 1999 Apr; 42(8):1393-400. PubMed ID: 10212125
[TBL] [Abstract][Full Text] [Related]
19. Conversion of A3 adenosine receptor agonists into selective antagonists by modification of the 5'-ribofuran-uronamide moiety.
Gao ZG; Joshi BV; Klutz AM; Kim SK; Lee HW; Kim HO; Jeong LS; Jacobson KA
Bioorg Med Chem Lett; 2006 Feb; 16(3):596-601. PubMed ID: 16289820
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological evaluation, and molecular modeling of ribose-modified adenosine analogues as adenosine receptor agonists.
Cappellacci L; Franchetti P; Pasqualini M; Petrelli R; Vita P; Lavecchia A; Novellino E; Costa B; Martini C; Klotz KN; Grifantini M
J Med Chem; 2005 Mar; 48(5):1550-62. PubMed ID: 15743197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
